NCT04501211 is a Phase 2 clinical trial of Granisetron in Gastroparesis, sponsored by Indiana University.

Who is sponsoring NCT04501211?

NCT04501211 is sponsored by Indiana University.

What drugs are being tested in NCT04501211?

Interventions in NCT04501211: Granisetron.

What condition does NCT04501211 study?

NCT04501211 studies Gastroparesis.

Is NCT04501211 still recruiting?

NCT04501211 is currently withdrawn. Last updated 14 February 2022.

Last reviewed 2022-02-14 · How we verify

NCT04501211

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

Withdrawn Phase 2 Last updated 14 February 2022

What this trial tests

Phase 2 trial testing Granisetron in Gastroparesis. Withdrawn.

Timeline

1 January 2019

Primary endpoint
31 December 2020

31 December 2021

Quick facts

Lead sponsor	Indiana University
Phase	Phase 2
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 January 2019
Primary completion	31 December 2020
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

Granisetron — full drug profile →

Conditions studied

Gastroparesis — all drugs for Gastroparesis →

Sponsor

Indiana University

Who can join

Adults 18 to 80, any sex, with Gastroparesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the efficacy of open -label transdermal patch on chronic nausea and emesis in patients with gastroparesis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Granisetron

Trials testing the same drug.

NCT06762860 — Intravenous Granisetron Vs Dexmedetomidine on Postspinal in the Cesarean Section. · NA · unknown
NCT05632224 — Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery · Phase 4 · unknown
NCT05087615 — Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariat · Phase 3 · completed
NCT04918862 — A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABI · Phase 3 · completed
NCT03817970 — Cisplatin Disposition and Kidney Injury · Phase 3 · active not recruiting

Other recruiting trials for Gastroparesis

Currently open trials in the same condition.

NCT04661215 — Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms · recruiting
NCT07104214 — Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy · recruiting
NCT07526935 — Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator · NA · active not recruiting
NCT05981300 — GpCRC Pediatric Gastroparesis Registry 2 · recruiting
NCT06580197 — The Role of AAT After Abdominal Surgery Based on RWS · recruiting

Other Indiana University trials

Trials by the same sponsor.

NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04501211 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indiana University
Last refreshed: 14 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04501211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing